Evolving our science to solve complex healthcare challenges
Dave Powell on why LifeArc is evolving the way we do our science – and the difference we hope it will make to people’s lives.
Twitter outputted an error:
Invalid or expired token..
Invalid or expired token..
2022 wrapped – our highlights from a pivotal year
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
LifeArc partners with EMBARC to improve healthcare for people living with bronchiectasis
Three-year partnership to improve healthcare for thousands of people across Europe living with bronchiectasis.
MND Collaborative Partnership cautiously welcomes new Government funding
We cautiously welcome the Government's announcement on how their £50m commitment into MND research will be spent.
Repurposed flu medicine could help under 60s recover faster from COVID-19
Results of an international repurposing study show favipiravir could help with COVID-19.
LifeArc bolsters executive team with communications expertise
Welcome to Anna Tomlinson, who joins LifeArc as our first Chief Communications Officer.
LifeArc announces £10m funding call for new chronic respiratory infection therapies
First major funding call announced as part of our £100m Chronic Respiratory Infection Translational Challenge
£100m programme to transform care for people living with chronic lung conditions
More than 300,000 people in the UK are living with bronchiectasis and more than 10,000 have been diagnosed with cystic fibrosis.
LifeArc responds to the Government’s renewed pledge to increase R&D funding
LifeArc CEO Dr Melanie Lee welcomes the Government’s restatement of its commitment to increase R&D funding in today’s Autumn statement: “Today the Chancellor made it clear that UK life science is a key driver of growth. “I am delighted that promises to raise the research and development (R&D) budget have been protected. It is the […]